ClinicoEconomics and Outcomes Research is an international, peerreviewed open-access journal focusing on health technology assessment, pharmacoeconomics and outcomes research in the areas of diagnosis, medical devices, and clinical, surgical and pharmacological intervention. The economic impact of health policy and health systems organization also constitute important areas of coverage. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors. Table 4 , first column: The last trastuzumab preparation item should be: "Median time to prepare trastuzumab (for median number of patients per day)".
On page 232, Table 5 , first column: Wording of the last outcome for each therapy should be: "Annual economic impact" rather than "Annual economic impact per patient".
On page 232, Table 5 , second column: "In breast cancer (trastuzumab)", the mean annual economic impact for the intravenous administration should be: €29,872.
On page 232, Table 5 , second column: The public price (hospital price) for subcutaneous administration should be: €2.89/mg.
